Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats.
about
Pharmacodynamics of fluconazole in a murine model of systemic candidiasis.Altered pharmacokinetics of piperacillin in febrile neutropenic patients with hematological malignancyPharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection.Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae.Clinical pharmacokinetics of cefamandole and ceftazidime administered by continuous intravenous infusion.Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infectionsAntimicrobial effects of continuous versus intermittent administration of carbapenem antibiotics in an in vitro dynamic model.In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patientsOnce daily ceftriaxone and gentamicin for the treatment of febrile neutropenia.Steady-state pharmacokinetics of imipenem in febrile neutropenic cancer patients.Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic ratsContinuous infusion of beta-lactam antibioticsPharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.Continuous beta-lactam infusion in critically ill patients: the clinical evidenceAntibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response.Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?Impact of dosage schedule of antibiotics on the treatment of serious infections.Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory.Role of pharmacokinetics in the outcome of infections.Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacinPharmacodynamic effects of subinhibitory concentrations of beta-lactam antibiotics in vitro.Beta-lactam antibiotics: is continuous infusion the preferred method of administration?Continuous infusion of ceftazidime in febrile neutropenic patients with acute myeloid leukemia.Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?Pharmacodynamics and alternative antimicrobial dosing regimensEffect of treatment duration on pharmacokinetic/pharmacodynamic indices correlating with therapeutic efficacy of ceftazidime in experimental Klebsiella pneumoniae lung infection.In vivo and in vitro study of several pharmacodynamic effects of meropenem.Effects of subminimal inhibitory concentrations of amoxicillin against Actinobacillus pleuropneumoniae.Impact of the duration of infection on the activity of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.Exposure time-dependent bactericidal activities of amoxicillin against Actinobacillus pleuropneumoniae; an in vitro and In vivo pharmacodynamic model.Efficacy evaluation of iclaprim in a neutropenic rat lung infection model with methicillin-resistant Staphylococcus aureus entrapped in alginate microspheres.
P2860
Q33695281-D4674725-62A9-4E8A-B1F1-159A0E1C2D39Q33797868-B6B86711-0172-4E59-AA05-186C0BF8C9ABQ33981666-9CE2D47B-48A7-403C-B321-9860F48B2148Q33983667-A64C994F-1AD2-407E-8751-C8AAB2E2EB7FQ35013772-BA20360D-70AD-40B5-AD85-070BF4891CA1Q35123123-A7B2261F-1A7D-4BFD-AB6E-9C5D24BFE32EQ35136449-4EA0B951-9AD2-49F4-949E-B6D20C0F0B2EQ35138316-F3363464-BCF2-451D-B767-3CBE4DD65E1DQ35262273-4B62988E-0A6C-4387-865D-75FF60B23FA8Q35541720-AD3423AF-9D50-4DD3-B576-8AEC07F8B082Q35543546-2D0D8150-2977-4611-9C0C-F5BFA9B38056Q35656806-A1AB1C0F-2168-4735-851D-E8DA9405F4A7Q35985436-589BC543-E27C-4A4F-BB57-A8AB7E020FB1Q36329228-F71F2719-5ED4-4A35-8B61-63B645492E74Q36554698-04697728-4B75-470A-A5C3-A9B756CE0570Q36863646-AA5A00C1-5C47-4AFD-A528-B65860134F86Q37516599-CCCF4DB7-6B85-4D3C-801C-C4950C53DF1CQ38035302-61D95796-73F6-477E-B8AF-7671E808DBC2Q38117578-65C4F96C-5116-4E9B-B7D1-134BAD77DE09Q38896040-BA95ABA5-6AA3-427D-8869-D3FD896E13BEQ39639407-CD079FF6-9211-43F5-82E3-5A972EA4E291Q39881775-43CD2009-3493-4EED-8917-0E2ABB62324BQ40087367-FE63F604-93E4-497F-909B-1E57585B4A71Q40459002-FA954BAD-DA8C-4CE7-B4E4-5A0BEBD50C7BQ40688395-BFD03B09-93D4-410C-84F2-3E40B34E5761Q41810184-8F54270B-F94C-4B9A-9C41-D2BF3A470571Q42432137-A0F0A22B-B3AD-492E-9FD1-AFBCC65DDCEBQ42543348-25E994D0-6F31-40E0-9412-1FDDE98A1CACQ43152276-B053C687-BF55-4662-BF62-C97E26364460Q43771580-4031EFDF-E90A-4621-A659-C08432F2AD48Q44251235-600DE515-6064-43A1-9464-4C16B80429D3Q44613093-10344AAD-5815-4AF1-A485-264AF64BE3D6Q44665771-C3400356-A2B1-4ECF-ADA0-742047BBDD6FQ49986454-7E4FDED2-0847-4C10-884B-06F56248075D
P2860
Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Continuous versus intermittent ...... in normal and leukopenic rats.
@ast
Continuous versus intermittent ...... in normal and leukopenic rats.
@en
type
label
Continuous versus intermittent ...... in normal and leukopenic rats.
@ast
Continuous versus intermittent ...... in normal and leukopenic rats.
@en
prefLabel
Continuous versus intermittent ...... in normal and leukopenic rats.
@ast
Continuous versus intermittent ...... in normal and leukopenic rats.
@en
P2093
P2860
P356
P1476
Continuous versus intermittent ...... in normal and leukopenic rats.
@en
P2093
Bakker-Woudenberg IA
Roosendaal R
van den Berghe-van Raffe M
P2860
P304
P356
10.1128/AAC.30.3.403
P407
P577
1986-09-01T00:00:00Z